resveratrol has been researched along with Vitreoretinopathy, Proliferative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, D; Kassumeh, S; Ohlmann, A; Priglinger, SG; Strehle, L; Tersi, N; Wertheimer, CM; Wolf, A | 1 |
| He, S; Hinton, DR; Ishikawa, K; Kannan, R; Nazari, H; Spee, C; Terasaki, H; Zhang, H | 1 |
2 other study(ies) available for resveratrol and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Pharmacological Therapy of Proliferative Vitreoretinopathy: Systematic
Topics: Dasatinib; Humans; Resveratrol; Retinal Pigment Epithelium; Simvastatin; Vitreoretinopathy, Proliferative | 2023 |
Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
Topics: Acetylation; Animals; Biomarkers; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibronectins; Rabbits; Resveratrol; Retinal Pigment Epithelium; Sirtuin 1; Smad4 Protein; Stilbenes; Transforming Growth Factor beta2; Vitreoretinopathy, Proliferative | 2015 |